











Title: Early pregnancy metabolic and inflammatory changes research study 

Lay title: The connection between early pregnancy changes in maternal blood biochemistry and pregnancy outcome

Invitation: You are being invited to take part in this research study. Before you decide it is important for you to understand why the research is being done and what it will involve. Please take time to read the following information carefully and discuss it with friends, relatives and your GP if you wish. Ask us if there is anything that is not clear or if you would like more information. Take time to decide whether or not you wish to take part.

Purpose of the Study:  Dr Dilys Freeman and colleagues at the University of Glasgow, Reproductive and Maternal Health Section are carrying out research into the connection between early pregnancy changes in blood biochemistry and pregnancy outcome. We would like to study whether changes in maternal blood markers of fat & carbohydrate metabolism and of inflammation are related to the successful outcome of pregnancy. We also want to study whether the body mass index of the mother is related to these blood changes. Finally we would like to see whether the blood changes in the mother are reflected in her baby at birth. We can do this by looking at the placenta, the attached umbilical cord and blood left in the cord at delivery. 

Why have you been chosen?: In order to monitor metabolic and inflammation markers in very early pregnancy we want to recruit women undergoing assisted conception. In particular we want to recruit women with a natural menstrual cycle undergoing frozen embryo transfer (FET). This means we will not confuse the effects of additional treatment hormones on blood markers with the changes we want to observe.

Do I have to take part?: It is up to you to decide whether or not to take part. If you do decide to take part you will be given this information sheet. We will ask for your written permission (a signature on the consent form). If you decide to take part you are still free to withdraw at any time and without giving a reason. This will not affect the standard of care you receive. The Consultants in the ACS Unit will be informed that you are taking part in the study.

What will happen to me if I take part?: In total you will be requested to provide 7 blood samples. Two blood samples (20mls each – about 2 tablespoons) will be taken routinely at approximately +10 days after the last menstrual period (baseline) and on the day of frozen embryo transfer (day 0).  An additional  five blood samples will be collected on approximately +3 days, +1 weeks, +2 weeks (routine outcome day), + 4 weeks and +6 weeks (routine pregnancy scan equivalent to 8 weeks' gestation) for research purposes only. Waist measurements will be collected at the first and last appointments. At delivery, the placenta and its attached umbilical cord with blood inside is delivered after the baby and is normally discarded because it has completed its function. In the study, instead of this tissue being discarded it will be passed onto the laboratory where it will be studied. 

What do I have to do?:  You will meet the researchers 7 times in the early part of the study for blood sampling. The blood samples should be taken when you are fasting. We will not ask you to have anything to eat or drink (other than water or black tea or coffee) for 10 hours prior to the appointment. We will make the appointments in the morning and provide you with some breakfast immediately after the sample has been taken. 

If frozen embryo transfer has resulted in a successful pregnancy, we will try and arrange to attend your delivery in order to collect the placenta and its attached umbilical cord with blood inside.  We will provide you with a sticker to put in your hand held hospital notes. This sticker informs the medical professionals that you are taking part in a study and asks them to contact the researchers at delivery so that we might arrange to collect the delivery samples.  When you contact the Assisted Conception Unit to provide information on the outcome of the antenatal booking scan (or respond to the routine letter requesting information) we will also ask for details on your estimated delivery date and the hospital at which you are booked to deliver. This means we are aware of when and where you are projected to deliver your baby and this will help in the arrangement of collecting delivery samples. Finally we will provide you with the contact details of the researchers such that should you be able to contact us when your attend the hospital for delivery you can also contact us.

What will happen to my and my baby’s blood/tissue?: We will measure a level of a number of different metabolites and indicators of inflammation in mother’s and baby’s blood. Some samples will be sent to our research collaborators in different research institutes where they can measure metabolites that we cannot. We will extract DNA from blood so that we can investigate the influence of any common genetic variants on the measurements we have made.  Any blood not used initially, in addition to the DNA and any placental or umbilical cord tissue will be stored frozen for future analysis. Often initial results require us to go back and check other measurements or new advances in science cause us to revisit samples to expand the primary information we collected. Studying the placental and umbilical cord tissue will help us understand how maternal levels of metabolites and inflammatory markers affect the baby. 

Tissue samples and data we collect from this study will be very useful to revisit as new research ideas emerge. Frozen tissue samples and the data on all the measures we have made will be stored in an anonymised form for up to 20 years.

Disadvantages and risks: Some individuals feel faint after giving blood and may need to rest afterwards.

Benefits of taking part: There will be no benefit of taking part to you. The research will provide useful information to help us work out any connection between early pregnancy metabolic and inflammatory changes and pregnancy outcome. The research may also help us to better manage or treat adverse pregnancy outcome such as miscarriage in the future.

Confidentiality: All information which is collected about you during the course of the research will be kept strictly confidential. Any information about you which leaves the hospital will have your name and address removed so that you cannot be recognised.

Results of the Study: New information that we gain from the study will be published in scientific journals. No specific individual from whom we have collected blood and tissue will be identified in these publications. These publications are available for all to read. 

Funding of the research: The research is being funded by the Wellbeing of Women charity (www.wellbeingofwomen.org.uk).

Review of the Study: The study has been reviewed by the Research Ethics Committee of Glasgow Royal Infirmary.





Your time in considering this research is very much appreciated.
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